Investigational Site Number 642004

Craiova 200385

0 studies enrolling now · 2 studies all time

What they study most

Non-small Cell Lung Cancer, Squamous Cell Lung Cancer

Studies at this site

• Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) — Completed
• Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer — Completed